How Much Weight Can You Lose on GLP-1?

What Clinical Trials Show

The landmark trials for GLP-1 weight loss medications have produced results that surprised even the researchers who ran them:

• Semaglutide (STEP 1 trial): Average weight loss of 14.9% of body weight at 68 weeks. One in three participants lost more than 20% of their body weight.
• Tirzepatide (SURMOUNT-1 trial): Average weight loss of 20.9% of body weight at 72 weeks on the highest dose. More than half of participants lost at least 20% of body weight.

To put this in context: previous prescription weight loss medications typically produced 5–8% weight loss. Bariatric surgery typically produces 25–35%. GLP-1 medications have bridged most of that gap non-surgically.

What Does This Mean in Pounds?

Results vary based on starting weight, but here are illustrative examples:

Timeline: What to Expect Week by Week

• Weeks 1–4: Appetite begins to decrease. Some nausea and adjustment as your body adapts to the starting dose. Weight loss is modest — 2–5 lbs is typical.
• Weeks 4–12: Dose increases begin. Appetite suppression deepens. Most people are consistently eating less and losing 1–2 lbs per week. Cumulative loss of 8–15 lbs.
• Months 3–6: Approaching your maintenance dose. Weight loss continues at a steady pace. Many patients reach 10–15% loss in this window.
• Months 6–12: Weight loss may slow as your body adjusts, but continues with the therapeutic dose. Most of the clinical trial results are measured at this 12-month mark.
• Beyond 12 months: Continued treatment typically sustains weight loss. Some patients continue to lose additional weight; others transition to a maintenance phase.

What Affects Your Results?

Individual variation in GLP-1 response is real. Several factors influence how much weight you will lose:

• Starting weight: Higher starting weights tend to produce larger absolute losses.
• Dose reached: Patients who reach and tolerate the maximum dose tend to lose more weight. Slow escalation matters.
• Diet quality: GLP-1 medications reduce appetite significantly but do not eliminate the importance of food quality. High-protein diets help preserve muscle during weight loss.
• Activity level: Exercise helps preserve muscle mass and can enhance total weight loss.
• Genetics and metabolism: Some people are stronger responders to GLP-1 agonists than others. If semaglutide produces limited results, tirzepatide may work better.
• Consistency: Missing doses or discontinuing early significantly reduces outcomes.

What Happens If You Stop Taking GLP-1?

This is one of the most important things to understand: GLP-1 medications treat obesity as a chronic condition. Clinical studies show that most people regain a significant portion of lost weight within 12 months of stopping treatment.

This does not mean the medication has failed — it reflects the biology of obesity. Just as someone with high blood pressure needs ongoing medication, many people benefit from long-term GLP-1 therapy. Your provider can help you develop a plan for either continued treatment or a sustainable transition strategy.